Skip to main content

Advertisement

SpringerLink
Log in

Ultrastructural characteristics of glucocorticoid-induced osteoporosis

  • Bone Quality Seminars: Ultrastructure
  • Published:
Osteoporosis International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Van Staa TP, Leufkens HGM, Abenhaim L, Zhang B, Cooper C (2000) Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15:993–1000

    Article  PubMed  Google Scholar 

  2. Van Staa TP, Leufkens HGM, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporosis Int 13:777–787

    Article  Google Scholar 

  3. Stahn C, Löwenberg M, Hommes DW, Buttgereit F (2007) Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists. Mol Cell Endocrinol 275:71–78

    Article  PubMed  CAS  Google Scholar 

  4. Vestergaard P, Rejnmark L, Mosekilde L (2008) Fracture risk associated with different types of oral corticosteroids and effect of termination of corticosteroids on the risk of fractures. Calcif Tissue Int 82:249–257

    Article  PubMed  CAS  Google Scholar 

  5. Hong D, Chen HX, Ge RS, Li JC (2008) The biological roles of extracellular and intracytoplasmic glucocorticoids in skeletal cells. J Steroid Biochem Mol Biol 111:164–170. doi:10.1016/j.jsbmb.2008.06.015

    Article  PubMed  CAS  Google Scholar 

  6. Eijken M, Koedman M, van Driel M, Buurman CJ, Pols HAP, Van Leeuwen JPTM (2006) The essential role of glucocorticoids for proper human osteoblast differentiation and matrix mineralization. Mol Cell Endocrinol 248:87–93

    Article  PubMed  CAS  Google Scholar 

  7. Atmani H, Audrain C, Mercier L, Chappard D, Baslé MF (2002) Phenotypic effects of continuous or discontinuous treatment with dexamethasone and/or calcitriol on osteoblasts differentiated from rat marrow stromal cells. J Cell Biochem 85:640–650

    Article  PubMed  CAS  Google Scholar 

  8. Ito S, Suzuki N, Kato S, Takahashi T, Takagi M (2007) Glucocorticoids induce the differentiation of a mesenchymal progenitor cell line, ROB-C26 into adipocytes and osteoblasts, but fail to induce terminal osteoblast differentiation. Bone 40:84–92

    Article  PubMed  CAS  Google Scholar 

  9. Canalis E, Mazziotti G, Giustina A, Bilezikian JP (2007) Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporosis Int 18:1319–1328

    Article  CAS  Google Scholar 

  10. Ohnaka K, Taniguchi H, Kawate H, Nawata H, Takayanagi R (2004) Glucocorticid enhances the expression of dickkopf-1 in human osteoblasts: novel mechanism of glucocorticoid-induced osteoporosis. Biochem Biophys Res Commun 318:259–264

    Article  PubMed  CAS  Google Scholar 

  11. Wang FS, Ko JY, Yeh CW, Ke HC, Wu HL (2008) Modulation of dickkopf-1 attenuates glucocorticoid induction of osteoblast apoptosis, adipocytic differentiation and bone mass loss. Endocrinology 149:1793–1801

    Article  PubMed  CAS  Google Scholar 

  12. Weinstein RS, Jilka RL, Parfitt M, Manolagas SC (1998) Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 102:274–282

    Article  PubMed  CAS  Google Scholar 

  13. O’brien CA, Jia D, Plotkin LI, Bellido T, Powers CC, Stewart SA, Manolagas SC, Weinstein RS (2004) Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology 145:1835–1841

    Article  PubMed  CAS  Google Scholar 

  14. Weinstein RS, Chen JR, Powers CC, Stewart SA, Landes RD, Bellido T, Jilka RL, Parfitt AM, Manolagas SC (2002) Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids. J Clin Invest 109:1041–1048

    PubMed  CAS  Google Scholar 

  15. Jia D, O'Brien CA, Stewart SA, Manolagas SC, Weinstein RS (2006) Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density. Endocrinlogy 147:5592–5599

    Article  CAS  Google Scholar 

  16. Kim HJ, Zhao H, Kitaura H, Bhattacharyya S, Brewer JA, Muglia LJ, Ross FP, Teitelbaum SL (2006) Glucocorticoids suppress bone formation via the osteoclast. J Clin Invest 116:2152–2160

    Article  PubMed  CAS  Google Scholar 

  17. Chappard D, Legrand E, Baslé MF, Fromont P, Racineux JL, Rebel A, Audran M (1996) Altered trabecular architecture induced by corticosteroids: a bone histomorphometric study. J Bone Miner Res 11:676–685

    Article  PubMed  CAS  Google Scholar 

  18. Chappard D, Josselin N, Rougé-Maillart C, Legrand E, Baslé MF, Audran M (2007) Bone microarchitecture in males with corticosteroid induced osteoporosis. Osteoporosis Int 18:487–494

    Article  CAS  Google Scholar 

  19. Canalis E (1983) Effect of glucocorticoids on type I collagen synthesis, alkaline phosphatase activity, and deoxyribonucleic acid content in cultured rat calvariae. Endocrinology 112:931–939

    Article  PubMed  CAS  Google Scholar 

  20. Delany AM, Gabgitas BY, Canalis E (1995) Cortisol downregulates osteoblast α1(I) procollagen mRNA by transcriptional and posttranscriptional mechanisms. J Cell Biochem 57:488–494

    Article  PubMed  CAS  Google Scholar 

  21. Giustina A, Mazziotti G, Canalis E (2008) Growth hormone, insulin-like growth factors and the skeleton. Endoc Rev 29:535–559. doi:10.1210/er.2007-0036

    Article  CAS  Google Scholar 

  22. Dalle Carbonare L, Bertoldo F, Valenti MT, Zenari S, Zanatta M, Sella S, Giannini S, Lo Cascio V (2005) Histomorphometric analysis of glucocorticoid-induced osteoporosis. Micron 36:645–652

    Article  PubMed  CAS  Google Scholar 

  23. Lane NE, Yao W, Balooch M, Nalla RK, Balooch G, Habelitz S, Kinney JH, Bonewald LF (2006) Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice. J Bone Miner Res 21:466–476

    Article  PubMed  CAS  Google Scholar 

  24. Balooch G, Yao W, Ager JW, Balooch M, Nalla RK, Porter AE, Ritchie RO, Lane NE (2007) The aminobisphosphonate risedronate preserves localized mineral and material properties of bone in the presence of glucocorticoids. Arthritis Rheum 56:3726–3737

    Article  PubMed  CAS  Google Scholar 

  25. Yao W, Cheng Z, Busse C, Pham A, Nakamura MC, Lane NE (2008) Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis. A longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice. Arthritis Rheum 58:1674–1686

    Article  PubMed  CAS  Google Scholar 

Download references

Conflicts of interest

None

Author information

Authors and Affiliations

  1. INSERM U922 “Remodelage osseux et biomatériaux”, Service de Rhumatologie CHU Angers, 49933, Angers, France

    B. Bouvard, M. Audran, E. Legrand & D. Chappard

Authors
  1. B. Bouvard
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Audran
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Legrand
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Chappard
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E. Legrand.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bouvard, B., Audran, M., Legrand, E. et al. Ultrastructural characteristics of glucocorticoid-induced osteoporosis. Osteoporos Int 20, 1089–1092 (2009). https://doi.org/10.1007/s00198-009-0864-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-009-0864-7

Keywords

Search

Navigation